Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study - PubMed (original) (raw)
Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study
Massimo Bellini et al. BMC Gastroenterol. 2017.
Abstract
Background: According to Rome criteria, chronic constipation (CC) includes functional constipation (FC) and irritable bowel syndrome with constipation (IBS-C). Some patients do not meet these criteria (No Rome Constipation, NRC). The aim of the study was is to evaluate the various clinical presentation and management of FC, IBS-C and NRC in Italy.
Methods: During a 2-month period, 52 Italian gastroenterologists recorded clinical data of FC, IBS-C and NRC patients, using Bristol scale, PAC-SYM and PAC-QoL questionnaires. In addition, gastroenterologists were also asked to record whether the patients were clinically assessed for CC for the first time or were in follow up. Diagnostic tests and prescribed therapies were also recorded.
Results: Eight hundred seventy-eight consecutive CC patients (706 F) were enrolled (FC 62.5%, IBS-C 31.3%, NRC 6.2%). PAC-SYM and PAC-QoL scores were higher in IBS-C than in FC and NRC. 49.5% were at their first gastroenterological evaluation for CC. In 48.5% CC duration was longer than 10 years. A specialist consultation was requested in 31.6%, more frequently in IBS-C than in NRC. Digital rectal examination was performed in only 56.4%. Diagnostic tests were prescribed to 80.0%. Faecal calprotectin, thyroid tests, celiac serology, breath tests were more frequently suggested in IBS-C and anorectal manometry in FC. More than 90% had at least one treatment suggested on chronic constipation, most frequently dietary changes, macrogol and fibers. Antispasmodics and psychotherapy were more frequently prescribed in IBS-C, prucalopride and pelvic floor rehabilitation in FC.
Conclusions: Patients with IBS-C reported more severe symptoms and worse quality of life than FC and NRC. Digital rectal examination was often not performed but at least one diagnostic test was prescribed to most patients. Colonoscopy and blood tests were the "first line" diagnostic tools. Macrogol was the most prescribed laxative, and prucalopride and pelvic floor rehabilitation represented a "second line" approach. Diagnostic tests and prescribed therapies increased by increasing CC severity.
Keywords: Diagnosis; Functional constipation; Irritable bowel syndrome; Treatment.
Similar articles
- Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
Bouchoucha M, Devroede G, Bon C, Bejou B, Mary F, Benamouzig R. Bouchoucha M, et al. Tech Coloproctol. 2017 Feb;21(2):125-132. doi: 10.1007/s10151-016-1580-x. Epub 2017 Jan 9. Tech Coloproctol. 2017. PMID: 28066860 - Management of chronic constipation in general practice.
Bellini M, Gambaccini D, Salvadori S, Tosetti C, Urbano MT, Costa F, Monicelli P, Mumolo MG, Ricchiuti A, De Bortoli N, Marchi S. Bellini M, et al. Tech Coloproctol. 2014 Jun;18(6):543-9. doi: 10.1007/s10151-013-1093-9. Epub 2013 Nov 22. Tech Coloproctol. 2014. PMID: 24272606 - Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.
Wong RK, Palsson OS, Turner MJ, Levy RL, Feld AD, von Korff M, Whitehead WE. Wong RK, et al. Am J Gastroenterol. 2010 Oct;105(10):2228-34. doi: 10.1038/ajg.2010.200. Epub 2010 May 25. Am J Gastroenterol. 2010. PMID: 20502449 Free PMC article. - Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation.
Whitehead WE, Palsson OS, Simrén M. Whitehead WE, et al. Neurogastroenterol Motil. 2016 Jun;28(6):783-92. doi: 10.1111/nmo.12852. Neurogastroenterol Motil. 2016. PMID: 27214096 Review. - Irritable bowel syndrome and chronic constipation: Fact and fiction.
Bellini M, Gambaccini D, Usai-Satta P, De Bortoli N, Bertani L, Marchi S, Stasi C. Bellini M, et al. World J Gastroenterol. 2015 Oct 28;21(40):11362-70. doi: 10.3748/wjg.v21.i40.11362. World J Gastroenterol. 2015. PMID: 26523103 Free PMC article. Review.
Cited by
- Frequency patterns of core constipation symptoms among the Asian adults: a systematic review.
Patimah AW, Lee YY, Dariah MY. Patimah AW, et al. BMC Gastroenterol. 2017 Nov 2;17(1):115. doi: 10.1186/s12876-017-0672-z. BMC Gastroenterol. 2017. PMID: 29096625 Free PMC article. Review. - Exploring Pharmacological Treatments for Chronic Idiopathic Constipation in Adults: A Look Back to the Future.
Bassotti G, Villanacci V, Corsetti M. Bassotti G, et al. J Clin Med. 2023 Feb 20;12(4):1702. doi: 10.3390/jcm12041702. J Clin Med. 2023. PMID: 36836237 Free PMC article. Review. - Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study.
Kamei D, Kamei Y, Nagano M, Mineshima M, Nitta K, Tsuchiya K. Kamei D, et al. BMC Gastroenterol. 2020 Jan 31;20(1):26. doi: 10.1186/s12876-020-1179-6. BMC Gastroenterol. 2020. PMID: 32005162 Free PMC article. - The Yield of Colonoscopy in the Evaluation of Constipation: An Age-Based Analysis of Outcome.
Abu Baker F, Mari A, Taher R, Nicola D, Gal O, Zeina AR. Abu Baker F, et al. J Clin Med. 2024 May 15;13(10):2910. doi: 10.3390/jcm13102910. J Clin Med. 2024. PMID: 38792451 Free PMC article. - Clinical Characteristics of Different Primary Constipation Subtypes in a Chinese Population.
Jiang Y, Tang Y, Lin L. Jiang Y, et al. J Clin Gastroenterol. 2020 Aug;54(7):626-632. doi: 10.1097/MCG.0000000000001269. J Clin Gastroenterol. 2020. PMID: 31592795 Free PMC article.
References
- Neri L, Basilisco G, Corazziari E, Stanghellini V, Bassotti G, Bellini M, Perelli I, Cuomo R, LIRS study group Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation. United European Gastroenterol J. 2014;2:138–47. doi: 10.1177/2050640614528175. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical